CATX Net Income Growth
Perspective Therapeutics Inc · Net Income Growth
CATX Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-26.70%period ending
CATX TTM Net Income YoY % (-101.79% → -26.70%)
Year-over-year change
High-resolution chart · PNG
CATX net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| -26.6992% | |
| -34.3858% | |
| -28.4033% | |
| -64.5579% | |
| -57.303% | |
| -44.4666% | |
| -64.9054% | |
| -151.945% | |
| -229.2437% | |
| -556.7577% | |
| -387.598% | |
| -172.4195% | |
| -144.0044% | |
| -39.3445% | |
| -71.4488% | |
| -85.0112% | |
| -114.7033% | |
| -78.0023% | |
| -70.5794% | |
| -47.0835% | |
| 1.7121% | |
| -4.8017% | |
| 15.7814% | |
| 24.9102% | |
| 33.0093% | |
| 47.6666% | |
| 40.487% | |
| 33.1632% | |
| 23.2124% | |
| -3.4221% | |
| -6.251% | |
| -7.2625% | |
| -8.7147% | |
| -12.7837% | |
| -16.7956% | |
| -19.6601% | |
| -30.8056% | |
| -20.4385% | |
| -23.3663% | |
| -32.5831% | |
| -27.9745% | |
| -5.4693% | |
| 20.8125% | |
| 28.4939% | |
| 38.2283% | |
| 18.0233% | |
| -39.6158% | |
| -32.4213% | |
| -54.5177% | |
| -29.668% | |
| -0.0164% | |
| -22.2934% | |
| -10.5417% | |
| -35.7874% | |
| -12.4555% | |
| -10.0146% | |
| -22.7499% | |
| 6.7353% | |
| -5.9806% | |
| 23.1675% | |
| 29.541% | |
| 23.6245% | |
| 28.6117% | |
| 24.174% | |
| 34.5243% | |
| 33.7496% | |
| 34.7768% | |
| 35.6183% | |
| 28.0066% | |
| 35.558% | |
| 27.476% | |
| 7.3035% | |
| 10.9071% | |
| -3.8141% | |
| -6.3552% | |
| 3.7966% | |
| -16.8776% | |
| -79.1538% | |
| -150.6587% | |
| -451.574% | |
| -1,855.231% | |
| -74,744.7368% | |
| -22,953.613% | |
| 979.3059% | |
| 89.2894% | |
| 87.9656% | |
| 79.1637% | |
| 45.6943% | |
| 30.4154% | |
| -1.5977% | |
| -125.9758% | |
| -127.2675% | |
| -127.6929% | |
| -125.1306% | |
| 403.4519% | |
| 437.6747% | |
| 448.182% | |
| 458.1179% | |
| -104.4158% | |
| -103.8201% |